In the context of the COVID-19 pandemic, many barriers to telemedicine disappeared.
Virtual visits and telemonitoring strategies became routine. Evidence is accumulating …

Most patients with heart failure (HF) have multiple comorbidities, which impact their quality of
life, aggravate HF, and increase mortality. Cardiovascular comorbidities include systemic …

Elevated intraocular pressure (IOP) is the leading cause of glaucoma. As glaucoma is an
irreversible neurological eye disease, it is urgent to realize timely and accurate IOP …

Abstract Protocatechuic acid (3, 4‐dihydroxybenzoic acid) prevents oxidative stress,
inflammation and cardiac hypertrophy. This study aimed to investigate the therapeutic effects …

Background and Objectives: Chronic venous disease (CVD) is a widespread clinical
condition that is very common in western countries in the adult general population with a …

The leading cause of death in patients with nonalcoholic fatty liver disease (NAFLD) is
cardiovascular disease (CVD). However, the mechanisms are unknown. Mice deficient in …

In heart disturbances, stable gastric pentadecapeptide BPC 157 especial therapy effects
combine the therapy of myocardial infarction, heart failure, pulmonary hypertension …

BACKGROUND: Apparent resistant hypertension (aRH) carries excess cardiovascular risk
beyond nonresistant forms of hypertension; however, our understanding of this at-risk …

Ischemic cardiomyopathy (ICM) is the most prevalent cause of heart failure (HF) in
developed countries, with significant morbidity and mortality, despite constant improvements …

Background Blood pressure (BP) is a continuous and dynamic measure. However, standard
BP control metrics may not reflect the variability in BP over time. Objectives This study …